A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Center for Clinical Studies, Texas
- Study ID
- NCT06903078
- Status
- Recruiting
Conditions
- Herpes Zoster (HZ)
- Vascular Dementia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The purpose of this observational research study is to study if patients with herpes zoster, also known as Shingles, have a higher risk of vascular dysfunction (problems with blood vessels, including stroke) and vascular dementia (problems with mental decline as a result of decreased blood flow to the brain) compared to patients without herpes zoster. Patients are evaluated based on the group they are assigned too: 1. Herpes Zoster (HZ) Group: individuals presenting with untreated herpes zoster. These participants will have 6 visits: * Day 1 = 1st day presenting to clinic with acute zoster * 7 days post zoster * 1 month after Day 1 * 3 months after Day 1 * 6 months after Day 1 * 12 months after Day 1 2. Control Group: individuals without herpes zoster o Day 1 (only 1 visit will be completed) This study does not have a study medication/device. Standard of care for all patients will be followed.
Key Dates
- Start date
- Feb 13, 2025
- Status verified
- Dec 2025
- Primary completion
- Jul 31, 2029
- Completion
- Aug 31, 2030
Study Design
- Enrollment
- 375 participants (estimated)
Arms
- Arm: HZ (Herpes Zoster) GroupParticipants with untreated acute herpes zoster outbreak.
- Arm: Control GroupParticipants without acute herpes zoster outbreak.
Primary Outcome Measure
Analyze exosome content for known vascular damaging proteins/miRNAs from matched control and HZ individuals over a 12-month period. [ Time Frame: From enrollment throughout the 5-year proposal period, occurring in a cyclical and overlapping manner. ]
Central Contacts
- Study Principal Investigator281-333-2288
- Director of Research281-333-2288
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center for Clinical Studies, LTD. LLP | Houston | Texas | 77004 | Mario Guerrero Stephen K. Tyring, MD (PRINCIPAL_INVESTIGATOR) |
| Center for Clinical Studies, LTD. LLP | Webster | Texas | 77598 | Stephen K Tyring, MD (PRINCIPAL_INVESTIGATOR) Patricia C Lee, MD (SUB_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Shingrix in Renal Transplant RecipientsPHASE3 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Imaging of Brain Amyloid Plaques in the Aging PopulationPHASE4 · Enrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Longitudinal Cognitive Assessment by BoCARecruiting · Alzheimer's Light LLC · Miami, Florida
- Cognitive and Vascular Functioning Following TBIRecruiting · Walter Reed National Military Medical Center · Bethesda, Maryland